[Congressional Record Volume 148, Number 67 (Wednesday, May 22, 2002)]
[House]
[Pages H2838-H2842]
From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]




WAIVING POINTS OF ORDER AGAINST CONFERENCE REPORT ON H.R. 3448, PUBLIC 
 HEALTH SECURITY AND BIOTERRORISM PREPAREDNESS AND RESPONSE ACT OF 2002

  Mr. LINDER. Mr. Speaker, by direction of the Committee on Rules, I 
call up House Resolution 427 and ask for its immediate consideration.
  The Clerk read the resolution, as follows:

                              H. Res. 427

       Resolved, That upon adoption of this resolution it shall be 
     in order to consider the conference report to accompany the 
     bill (H.R. 3448) to improve the ability of the United States 
     to prevent, prepare for, and respond to bioterrorism and 
     other public health emergencies. All points of order against 
     the conference report and against its consideration are 
     waived. The conference report shall be considered as read.

  The SPEAKER pro tempore (Mr. Dan Miller of Florida). The gentleman 
from Georgia (Mr. Linder) is recognized for 1 hour.
  Mr. LINDER. Mr. Speaker, for the purpose of debate only, I yield the 
customary 30 minutes to the gentlewoman from New York (Ms. Slaughter) 
pending which I yield myself such time as I may consume. During 
consideration of this resolution, all time yielded is for the purpose 
of debate only.
  Mr. Speaker, H. Res. 427 is a rule providing for the consideration of 
the conference report for H.R. 3448, the bioterrorism bill. The rule 
waives all points of order against the conference report and against 
its consideration. It also provides that the conference report shall be 
considered as read.
  The Committee on Rules approved this rule last night, and I urge my 
colleagues to support it so that we can proceed with an hour of debate 
and consideration of this bipartisan conference report.
  Mr. Speaker, I want to take this opportunity to applaud the 
commendable work of my friends and colleagues on the Committee on 
Energy and Commerce for the work they have done to bring this final 
bill to the floor today. The gentleman from Louisiana (Mr. Tauzin), the 
committee chairman, and the gentleman from North Carolina (Mr. Burr), 
along with the gentleman from Georgia (Mr. Chambliss), who is the 
chairman of the Intelligence Subcommittee on Terrorism and Homeland 
Security, all of whom played an instrumental role in securing the much-
needed $600 million in authorization for the

[[Page H2839]]

Centers for Disease Control and Prevention to upgrade and enhance its 
facilities over the next 2 years, which is one of the conference 
report's most noteworthy proposals.
  Among the many good things that this bill does, it included a bill 
that I introduced in the first part of November that will allow the 
reauthorization of the building-out of the CDC. Mr. Speaker, the CDC is 
a group of world class intellects in a Third World facility. It has no 
security. They have scientists working on computers that are covered by 
polyethylene so that leaking roofs do not destroy them.
  As the American people recover from the discovery of anthrax in our 
mail system last year, we will continue to turn to the CDC for new ways 
to confine and eradicate these dangerous threats to the public health. 
This enhanced funding for the CDC to upgrade its facilities will be an 
important part of that process, and I look forward to President Bush, 
who visited the CDC with the gentleman from Georgia (Mr. Chambliss), 
myself and other members of the Georgia congressional delegation last 
year, I look forward to him signing this measure into law.
  Mr. Speaker, I reserve the balance of my time.
  Ms. SLAUGHTER. Mr. Speaker, I yield myself such time as I may 
consume.
  (Ms. SLAUGHTER asked and was given permission to revise and extend 
her remarks, and include extraneous material.)
  Ms. SLAUGHTER. Mr. Speaker, I thank the gentleman from Georgia (Mr. 
Linder) for yielding me the customary half hour.
  I rise in support of the underlying conference report. The 
Bioterrorism and Response Act enjoys strong bipartisan support, having 
passed the House by a vote of 418 to 2. Moreover, this measure moved 
forward the consultations from both sides of the aisle, a practice all 
too rare in the current Congress.

                              {time}  1030

  Mr. Speaker, this bioterrorism measure represents the first 
comprehensive effort to shore up our Nation's defenses against a terror 
attack. This includes critical provisions calling for the stockpiling 
of drugs and vaccines. It outlines initiatives to help prevent, detect, 
and treat terrorism-related health threats, including the possibility 
of a smallpox epidemic. Moreover, the legislation authorizes 
substantial new spending to help State and local health officials 
prepare for bioterrorism attacks. Grants would be made available to 
help hospitals prepare for the treatment of victims. Funding for 
research and prevention and treatment would also be increased.
  Of utmost importance, the bill ensures that additional steps would be 
taken to protect the food supply, including new authority for the FDA 
to bar unsafe food from entering the country. Many of us have long felt 
that the increased imports of food from countries outside the scope of 
U.S. safety regulation posed a unique threat to our citizens, 
especially with the advent of bioterrorism. The measure begins to 
address this concern by providing needed grants to States to strengthen 
food inspections and deal with outbreaks of food-borne illnesses. New 
registration and recordkeeping requirements would be imposed and safety 
improvements would be ordered at animal research labs.
  Mr. Speaker, I would also like to highlight the provisions of the 
legislation designed to protect our most vulnerable citizens in the 
event of terrorist attack: our children. I was proud to join my 
colleague from New York, Senator Hillary Clinton, in introducing the 
Protecting America's Children Against Terrorism Act. The bill provided 
Federal resources and coordination to ensure that our children's needs 
are met in the event of a terrorist attack. I wish to thank the 
chairman of the Committee on Energy and Commerce, the gentleman from 
Louisiana (Mr. Tauzin), and the ranking member, the gentleman from 
Michigan (Mr. Dingell), for including the majority of these provisions 
in this comprehensive measure.
  The events of September 11 have illustrated only too clearly for us 
the risks posed to our children by terrorism. Children perished aboard 
the planes that crashed. Both the World Trade Center and the Pentagon 
housed day care centers. Nearby schools had to be evacuated, and an 
estimated 10,000 American children lost a parent as a result of these 
atrocities, many of them losing their sole or primary caregiver.
  In recent months, new concerns have emerged. With the threat of 
bioterrorism and chemical warfare more prominent, we have realized that 
the proper dosages of vaccines and antidotes for children is 
incomplete. Few health care providers are trained to recognize the 
early signs of smallpox or anthrax, which can mimic cold or flu 
symptoms. The National Pharmaceutical Stockpile Program is not 
necessarily equipped with the supplies necessary to administer drugs or 
other treatment to large numbers of children.
  Other needs have become evident as well. Many schools lack effective 
evacuation plans or methods of moving children to an alternative safe 
location. Networks do not exist for informing parents of evacuations 
and the sites where their children may be found. Mental health services 
are not always available for children traumatized by catastrophic 
events.
  The conference report includes our proposal to protect children 
against bioterrorism by examining the preparedness of our Nation's 
health system for mass casualties of children and youth resulting from 
bioterrorism. It would establish an information network to collect and 
disseminate information for health providers on how to prepare for a 
biological terrorist attack and what steps to take to ensure children 
get the health care they need in the case of an attack. Moreover, the 
measure would ensure that the National Pharmaceutical Stockpile Program 
includes inventories to meet the medical needs of children.
  The events of September 11 have revealed to us the gaps in our 
preparedness for a major disaster. We owe it to all our citizens to 
ensure that we close these gaps before a future emergency, be it 
terrorism, natural disaster, or other cause, requires that we take 
action.
  Mr. Speaker, I reserve the balance of my time.
  Mr. LINDER. Mr. Speaker, I am pleased to yield such time as he may 
consume to the gentleman from Louisiana (Mr. Tauzin), the chairman of 
the committee.
  Mr. TAUZIN. Mr. Speaker, I thank the Committee on Rules for bringing 
this rule to the floor today.
  After 9-11, the Committee on Energy and Commerce began a series of 
roundtables with the agencies under our jurisdiction and members of 
both sides of our committee. The gentleman from Michigan (Mr. Dingell), 
leading the minority, and myself representing the majority, had 
meetings with the agency officials under our jurisdiction to ask 
several questions, the most of important of which was: tell us a little 
bit about where your vulnerabilities are; tell us a little bit about 
where you are not prepared; and tell us a little bit about how Congress 
might enact new laws and new authorities to make you better prepared 
for the things we might now expect, that indeed might now threaten our 
country in ways we were never before threatened.
  9-11 taught us a lesson, in effect. It taught us that we have to be 
willing to think like evil people. And that is not our custom. We think 
like good people in America. We do not think like evil people, 
designing ways and means to kill and destroy and to disrupt the lives 
of citizens who are innocent and have nothing to do with our cause. We 
think literally so totally different from the kind of enemy we now face 
in this terrorist situation that it was difficult for agency heads and 
even Members of Congress to think about all the things that someone 
with an evil mind might want to do to our citizens and our 
constituents; what they might want to do to this country and to the 
people that live here.
  So as we began to have those discussions with agencies under our 
jurisdictions, we suddenly realized how necessary it was to put 
together a bioterrorism package. And here, Mr. Speaker, I want to thank 
the gentleman from Georgia (Mr. Linder) for the excellent work he did 
in bringing to our committee ideas about how to make the CDC a much 
more functional and a much more effective agency for our

[[Page H2840]]

country, in not only just studying the prevention and treatment of 
diseases that are normal in our society, but now making sure we have 
the vaccines and the research going forward to protect us against the 
artificial insertion of biochemical and biological threats to our 
people, as we have now learned is possible. I want to thank him for 
bringing to our committee and to this bill the great ideas he had about 
beefing up the capacity of the CDC to do that for our country.
  But as we began to hear from these agency heads, we began to learn 
that, indeed, we had a lot of vulnerabilities in our country; that we 
did not have enough vaccine, for example, to make sure if anthrax were 
introduced into our society to harm us we could vaccinate enough people 
in our country. So we set to work immediately to make sure our health 
department not only got the right amount of vaccine available for us, 
but that our health agencies were all preparing to make sure that other 
vaccines and other treatments were available to first responders in 
case we had such an evil attack on our people.
  We learned, for example, that we had to organize better the laws that 
protected against people owning and transferring biological agents to 
one another so that we might find the owner or the possessor of an 
agent that enters our mail, for example, and begins to kill our people, 
whether it is a domestic threat or a foreign threat; that we had to 
make it illegal for someone to transfer the possession of some of these 
agents, if in fact they were legally in their possession, to make it 
criminally wrong for them to transfer it without authority, without a 
permit.
  We learned, for example, that our first responders were woefully 
unprepared in the case of a biological or chemical threat to our 
country to deal with the kind of casualties we might expect if 
something like that happened. We learned that we needed, for example, 
to beef up the capacity of our ambulance services and our nurses and 
our hospitals to deal with those kinds of problems, if, God forbid, 
they should happen in our country. This bill, for example, will provide 
another $520 million to the hospitals of America, a special help in 
grants, to make sure they are prepared for those kinds of emergencies.
  We learned also that our drinking water supplies needed to be better 
protected and safeguarded. We learned that, indeed, the incredible 
ability of someone to damage our country, who thinks as evilly as some 
of these people do, might find its way into threats against our water 
supplies. Just recently, I think last month, people were caught filming 
a water reservoir, I think in Connecticut. And we began to think, well, 
maybe people might indeed want to threaten the safe drinking water of 
our citizens, if they have such evil minds.
  I was reminded in all these meetings of that aircraft that took off 
from New York City, I think it was Egyptian Air; and instead of landing 
somewhere at its final destination, some pilot dove that plane into the 
ocean. I was reminded of when that happened and reminded that most of 
us in America thought how awful it was that if this pilot did indeed 
want to commit suicide, if that was really his purpose, why did he have 
to take all these innocent people along with him.

  It dawned on us, that is the way good people see an incident like 
that. The way evil people saw that incident was, perhaps in a desert 
somewhere or a cave somewhere in Afghanistan, he could have taken out 
more people had he taken that plane into a building. That is the way 
evil people think, how much more destruction he could have rendered had 
he done something different instead of just crashing the plane into the 
ocean.
  So through these meetings, through all this work we have done on the 
bioterrorism legislation, we have tried the awful exercise of thinking 
as evilly as we could. What would the most evil person try to do to us 
with biological threats, with chemical threats, with agents of 
destruction? What would the most evil person do to disrupt our health 
supply system or to disrupt our clean water system, to make sure we did 
not have enough clean drinking water perhaps, to poison that system or 
cause people death and injury? What would the most evil mind try to do 
if they learned how to fly a crop duster or a mosquito spraying plane 
and take that equipment somewhere and spread biological or chemical 
agents upon our people?
  We went through that awful exercise of trying to think like the most 
evil person on Earth and then tried to write a bill to make sure the 
agents of our government, those who are in charge of our health care 
system, those in charge of building our vaccine supplies, those in 
charge of testing biological agents, the first responders and those in 
charge of our incredibly sensitive clean drinking water supplies, what 
would we do in a bill to bolster our ability to meet those kinds of 
threats?
  So, last December, our committee presented to this body our 
bioterrorism package, and this body approved it overwhelmingly, I think 
430-some odd votes to 2, and sent that package on to the Senate. The 
Senate, similarly, passed a bill that mirrored in many aspects the 
House-passed version. It was passed unanimously in the Senate, and 
Senator Ted Kennedy and I have worked since that date in December to 
bring the best of those two packages together into a single package 
that we might present to the House and get signed by the President so 
that this country might be just a little safer from those evil minds 
who threaten, or would try to threaten, our country.
  This week we have learned about new threats. This week we have 
learned that the level of communications among al Qaeda operatives 
around the world is beginning to rise again, and that there are 
conversations about hitting this country again. We have heard testimony 
in the last few days that maybe it is not if, it is when. Maybe, 
indeed, we have to think about the inevitability of some strike against 
our people again. So we better have our first responders ready. We had 
better have enough vaccines ready. We had better have enough treatment 
facilities available. We had better make sure we protect the drinking 
water of our people as much as we can. We had better make sure our 
hospitals and our nurses and our ambulances, and all our firefighters, 
all those heroes of 9-11, are as well equipped as we can make them to 
respond as quickly as possible to the next set of threats that are 
leveled against our country.
  And so we have brought together in this conference the best of the 
Senate bill and the best of the House bill. And I want to compliment 
Senator Ted Kennedy and the Senate team for working so well with our 
team on the House side. In the end, I think we present an excellent 
package for the consideration of both bodies for the President to sign. 
And I cannot think of a better week than this week, when everybody's 
attention is riveted again on the new threats that are being talked 
about in conversations around the world against our people, that we 
pass this bioterrorism package and put it on the President's desk for 
his signature.
  We have included one extra thing of significant importance that I 
also want to mention. Up this year for renewal is something called 
PDUFA. It is an acronym for a policy that has allowed this country to 
collect user fees from the drug companies, the big pharmaceutical 
companies of America, and those user fees pay the salaries of people 
who work at the FDA, the Food and Drug Administration.
  That Food and Drug Administration set of personnel then do the 
testing, the analysis, all the research, all the professional analysis 
that goes into making sure that the pharmaceutical drugs that are 
patented in this country are tested first before a pharmaceutical 
company is allowed to sell them to your mom and your dad and your 
relatives, and even to those of us who need those drugs to survive or 
treat an illness.

                              {time}  1045

  The importance of that program, that prescription drug user fee 
program, is critical in America, and it is about to expire. It expires 
in September. If we do not reauthorize it this year, immediately, we 
begin laying off people at the Food and Drug Administration. So we have 
included in this package the reauthorization of the Prescription Drug 
User Fee Act which funds the work that goes forward to make sure that 
new prescription drugs

[[Page H2841]]

are properly tested before the Food and Drug Administration authorizes 
any pharmaceutical company to allow a doctor to prescribe them to the 
citizens of this country.
  And so we have brought you a good package that we think draws from 
the best of the House and the Senate versions of bioterrorism and we 
have added to it the reauthorization of the Prescription Drug User Fee 
Act. This package again represents this Nation's first line of defense 
against bioterrorism at a day and at a time when all of us know now 
that there are people who would love to disrupt this society by 
attacking us with one of those forms. When you think about 9/11 again 
and the awful consequences of 9/11 and you sit in a cave now in 
Afghanistan and think about how much more damage you might do to this 
country than you did on 9/11, bioterrorism is one of those areas we 
have to be concerned about. This bill gives this country many more 
tools to work with to defend and protect our people. It adds a whole 
new arsenal of first responder capabilities to in fact respond if we do 
get hit again, and it gives us the reauthorization of the Prescription 
Drug User Fee Act, a critically important act for the continuation of 
prescription drug protections for our country.
  I again want to thank the Committee on Rules for doing such an 
expeditious job last night late in bringing this rule to the floor so 
we can pass it before the Memorial Day recess.
  Ms. SLAUGHTER. Mr. Speaker, I yield 3 minutes to the gentleman from 
Ohio (Mr. Kucinich).
  Mr. KUCINICH. I thank the gentlewoman for yielding me this time.
  Mr. Speaker, in the bioterrorism conference report, House leadership 
managed to put in a new provision that would allow Medicare HMOs more 
time to decide whether or not to continue offering health plans. This 
would allow HMOs to delay for 2\1/2\ months telling senior citizens if 
they will continue to offer health insurance to them. Is this not a bit 
out of place? We are going to have a Medicare provision in legislation 
that helps the country prepare for a bioterrorism attack. This is what 
causes the American people to wonder what in the world we do here.
  We have a bill on the floor dealing with bioterrorism and suddenly it 
is also a bill that deals with Medicare HMOs. Here is a Medicare 
provision in legislation that helps prepare the country for a 
bioterrorist attack. Strange, because the Medicare+Choice program is 
wholly unrelated to bioterrorism. This provision was not considered by 
a committee. This provision was not considered in the underlying bill 
in the House or the Senate. It was added to the conference report at 
the very last minute. This is just another example of how the 
leadership is able to circumvent the established process and of the way 
business is done in this House. The only purpose, repeat, the only 
purpose of this provision is to help the insurance industry by giving 
HMOs more time to calculate revenue and estimate profits for next year. 
Every year, the Medicare+Choice program drops seniors to the tune of 
about a half a million seniors in the last year. Not only do senior 
citizens lose their coverage, but HMOs in the program have increased 
premiums, hiked up copayments, decreased benefits, and eliminated 
coverage year after year. Now, under this provision, seniors will have 
even less time to review their options for getting the health care that 
they will need. Allowing Medicare HMOs a 2\1/2\-month delay is not good 
for seniors. It certainly should not be added to the program. And most 
of all, Mr. Speaker, it should not be in a conference report for the 
Bioterrorism Preparedness Act.
  I call upon all Members to take note of exactly what happened in 
slipping this provision into a conference report on bioterrorism, and I 
call upon all Members to remember the senior citizens in our districts 
who are being thrown out of health care coverage by Medicare HMOs and 
an insurance industry which does not give a darn about the senior 
citizens.
  Mr. LINDER. Mr. Speaker, I yield 2 minutes to the gentleman from 
Louisiana (Mr. Tauzin).
  Mr. TAUZIN. I thank my friend for yielding me this time.
  Mr. Speaker, I wanted to read into the Record some of the names of 
the incredible staff who helped finalize this important work for the 
country. They include the head of our health team, Pat Morrisey, Brent 
DelMonte, Amit Sachdev, Nandan Kenkeremath, Allan Slobodin, Tom 
DiLenge, Steve Tilton; and of the legislative counsel, Pete Goodlow. 
These are staffers who worked tirelessly day and night and, believe me, 
all night, weekends, to make this possible. So many times we fail to 
say thank you to them. I just wanted to say on the record, thank you, 
team.
  Ms. SLAUGHTER. Mr. Speaker, I have no further requests for time, and 
I yield back the balance of my time.
  Mr. LINDER. Mr. Speaker, I urge my colleagues to support this rule so 
we can begin the debate on this important conference report.
  Mr. Speaker, I yield back the balance of my time, and I move the 
previous question on the resolution.
  The previous question was ordered.
  The SPEAKER pro tempore (Mr. Dan Miller of Florida). The question is 
on the resolution.
  The question was taken; and the Speaker pro tempore announced that 
the ayes appeared to have it.
  Ms. SLAUGHTER. Mr. Speaker, I object to the vote on the ground that a 
quorum is not present and make the point of order that a quorum is not 
present.
  The SPEAKER pro tempore. Evidently a quorum is not present.
  The Sergeant at Arms will notify absent Members.
  A record vote on the Journal will be a 5-minute vote immediately 
following this 15-minute vote.
  The vote was taken by electronic device, and there were--yeas 403, 
nays 19, not voting 12, as follows:

                             [Roll No. 186]

                               YEAS--403

     Abercrombie
     Ackerman
     Aderholt
     Akin
     Allen
     Andrews
     Armey
     Baca
     Bachus
     Baird
     Baker
     Baldacci
     Baldwin
     Ballenger
     Barcia
     Barr
     Barrett
     Bartlett
     Barton
     Bass
     Becerra
     Bentsen
     Bereuter
     Berkley
     Berman
     Berry
     Biggert
     Bilirakis
     Bishop
     Blagojevich
     Blumenauer
     Blunt
     Boehlert
     Boehner
     Bonilla
     Bonior
     Bono
     Boozman
     Borski
     Boswell
     Boucher
     Boyd
     Brady (PA)
     Brady (TX)
     Brown (FL)
     Brown (OH)
     Brown (SC)
     Bryant
     Burr
     Buyer
     Callahan
     Calvert
     Camp
     Cannon
     Cantor
     Capito
     Capps
     Capuano
     Cardin
     Carson (IN)
     Carson (OK)
     Castle
     Chabot
     Chambliss
     Clay
     Clayton
     Clement
     Clyburn
     Coble
     Collins
     Combest
     Condit
     Cooksey
     Costello
     Cox
     Coyne
     Cramer
     Crane
     Crenshaw
     Crowley
     Cubin
     Culberson
     Cummings
     Cunningham
     Davis (CA)
     Davis (FL)
     Davis (IL)
     Davis, Jo Ann
     Davis, Tom
     Deal
     DeGette
     Delahunt
     DeLauro
     DeLay
     DeMint
     Diaz-Balart
     Dicks
     Dingell
     Doggett
     Dooley
     Doolittle
     Doyle
     Dreier
     Duncan
     Dunn
     Edwards
     Ehlers
     Engel
     English
     Eshoo
     Etheridge
     Evans
     Everett
     Farr
     Fattah
     Ferguson
     Flake
     Fletcher
     Foley
     Forbes
     Ford
     Fossella
     Frank
     Frelinghuysen
     Frost
     Gallegly
     Ganske
     Gekas
     Gephardt
     Gibbons
     Gilchrest
     Gillmor
     Gilman
     Gonzalez
     Goode
     Goodlatte
     Gordon
     Goss
     Graham
     Granger
     Graves
     Green (TX)
     Green (WI)
     Greenwood
     Grucci
     Gutierrez
     Gutknecht
     Hall (OH)
     Hall (TX)
     Hansen
     Harman
     Hart
     Hastings (FL)
     Hastings (WA)
     Hayes
     Hayworth
     Hefley
     Herger
     Hill
     Hilleary
     Hilliard
     Hinojosa
     Hobson
     Hoeffel
     Hoekstra
     Holden
     Holt
     Honda
     Hooley
     Horn
     Hostettler
     Houghton
     Hoyer
     Hulshof
     Hunter
     Hyde
     Inslee
     Isakson
     Israel
     Issa
     Istook
     Jackson (IL)
     Jackson-Lee (TX)
     Jefferson
     Jenkins
     John
     Johnson (CT)
     Johnson (IL)
     Johnson, E. B.
     Johnson, Sam
     Jones (NC)
     Jones (OH)
     Kanjorski
     Kaptur
     Keller
     Kelly
     Kennedy (MN)
     Kennedy (RI)
     Kerns
     Kildee
     Kilpatrick
     Kind (WI)
     King (NY)
     Kingston
     Kirk
     Kleczka
     Knollenberg
     Kolbe
     LaFalce
     LaHood
     Lampson
     Langevin
     Lantos
     Larsen (WA)
     Larson (CT)
     Latham
     LaTourette
     Leach
     Levin
     Lewis (CA)
     Lewis (GA)
     Lewis (KY)
     Linder
     Lipinski
     LoBiondo
     Lofgren
     Lowey
     Lucas (KY)
     Lucas (OK)
     Luther
     Lynch
     Maloney (CT)
     Maloney (NY)
     Manzullo
     Markey
     Matheson
     Matsui
     McCarthy (MO)
     McCarthy (NY)
     McCollum
     McCrery
     McGovern
     McHugh
     McInnis
     McIntyre
     McKeon
     McKinney
     McNulty
     Meehan
     Meeks (NY)
     Menendez
     Mica
     Millender-McDonald
     Miller, Dan
     Miller, Gary
     Miller, Jeff
     Mink
     Mollohan
     Moore
     Moran (KS)
     Moran (VA)
     Morella
     Myrick
     Nadler
     Napolitano
     Neal
     Nethercutt
     Ney
     Northup
     Norwood
     Nussle
     Oberstar
     Obey
     Olver

[[Page H2842]]


     Ortiz
     Osborne
     Ose
     Otter
     Oxley
     Pallone
     Pascrell
     Pastor
     Paul
     Pelosi
     Pence
     Peterson (MN)
     Peterson (PA)
     Petri
     Phelps
     Pickering
     Pitts
     Platts
     Pombo
     Pomeroy
     Portman
     Price (NC)
     Pryce (OH)
     Putnam
     Quinn
     Radanovich
     Rahall
     Ramstad
     Regula
     Rehberg
     Reyes
     Reynolds
     Rivers
     Rodriguez
     Roemer
     Rogers (KY)
     Rogers (MI)
     Rohrabacher
     Ros-Lehtinen
     Ross
     Rothman
     Roukema
     Roybal-Allard
     Royce
     Rush
     Ryan (WI)
     Ryun (KS)
     Sabo
     Sanchez
     Sandlin
     Sawyer
     Saxton
     Schiff
     Schrock
     Scott
     Sensenbrenner
     Serrano
     Sessions
     Shadegg
     Shaw
     Shays
     Sherman
     Sherwood
     Shimkus
     Shows
     Shuster
     Simmons
     Simpson
     Skeen
     Skelton
     Slaughter
     Smith (MI)
     Smith (NJ)
     Smith (TX)
     Smith (WA)
     Solis
     Souder
     Spratt
     Stearns
     Stenholm
     Stump
     Sullivan
     Sununu
     Sweeney
     Tancredo
     Tanner
     Tauscher
     Tauzin
     Taylor (MS)
     Taylor (NC)
     Terry
     Thomas
     Thompson (CA)
     Thompson (MS)
     Thornberry
     Thune
     Thurman
     Tiahrt
     Tiberi
     Tierney
     Toomey
     Turner
     Udall (CO)
     Udall (NM)
     Upton
     Velazquez
     Visclosky
     Vitter
     Walden
     Walsh
     Wamp
     Watkins (OK)
     Watson (CA)
     Waxman
     Weiner
     Weldon (FL)
     Weldon (PA)
     Weller
     Wexler
     Whitfield
     Wicker
     Wilson (NM)
     Wilson (SC)
     Wolf
     Woolsey
     Wu
     Wynn
     Young (AK)
     Young (FL)

                                NAYS--19

     Conyers
     DeFazio
     Filner
     Hinchey
     Kucinich
     Lee
     McDermott
     Miller, George
     Owens
     Payne
     Rangel
     Sanders
     Schakowsky
     Stark
     Strickland
     Stupak
     Towns
     Waters
     Watt (NC)

                             NOT VOTING--12

     Burton
     Deutsch
     Ehrlich
     Emerson
     Mascara
     Meek (FL)
     Murtha
     Riley
     Schaffer
     Snyder
     Traficant
     Watts (OK)

                              {time}  1113

  Mr. TOWNS and Mr. WATT of North Carolina changed their vote from 
``yea'' to ``nay.''
  Mr. MALONEY of Connecticut and Mr. HOUGHTON changed their vote from 
``nay'' to ``yea.''
  So the resolution was agreed to.
  The result of the vote was announced as above recorded.
  A motion to reconsider was laid on the table.
  Stated for:
  Mr. EHRLICH. Mr. Speaker, on rollcall No. 186 I was inadvertently 
detained. Had I been present, I would have voted ``yea.''

                          ____________________